Does PEGVISOMANT Cause Insulin-like growth factor increased? 320 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 320 reports of Insulin-like growth factor increased have been filed in association with PEGVISOMANT (SOMAVERT). This represents 10.6% of all adverse event reports for PEGVISOMANT.
320
Reports of Insulin-like growth factor increased with PEGVISOMANT
10.6%
of all PEGVISOMANT reports
2
Deaths
43
Hospitalizations
How Dangerous Is Insulin-like growth factor increased From PEGVISOMANT?
Of the 320 reports, 2 (0.6%) resulted in death, 43 (13.4%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Insulin-like growth factor increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGVISOMANT. However, 320 reports have been filed with the FAERS database.
What Other Side Effects Does PEGVISOMANT Cause?
Off label use (460)
Drug ineffective (328)
Product dose omission issue (255)
Headache (244)
Fatigue (224)
Arthralgia (184)
Death (162)
Injection site pain (161)
Product use issue (158)
Diarrhoea (151)
What Other Drugs Cause Insulin-like growth factor increased?
SOMATROPIN (521)
OCTREOTIDE (261)
LANREOTIDE (106)
ATORVASTATIN (59)
METFORMIN (44)
CABERGOLINE (41)
AMLODIPINE (40)
PASIREOTIDE (21)
LOSARTAN (20)
CANDESARTAN (18)
Which PEGVISOMANT Alternatives Have Lower Insulin-like growth factor increased Risk?
PEGVISOMANT vs PEGZEREPOETIN ALFA
PEGVISOMANT vs PEMBROLIZUMAB
PEGVISOMANT vs PEMETREXED
PEGVISOMANT vs PEMIGATINIB
PEGVISOMANT vs PENICILLAMINE